Skip to content

Which of the following indicates intolerance of enteral nutrition support?

4 min read

According to a study published in the Chinese Medical Journal in 2023, feeding intolerance was a frequent and early complication in critically ill patients receiving enteral nutrition. Recognizing the signs of intolerance is crucial for timely intervention and to prevent complications like aspiration pneumonia, malnutrition, and dehydration. This guide explores the key indicators and causes of enteral feeding intolerance, as well as management strategies.

Quick Summary

This guide details the key symptoms and clinical signs of enteral nutrition intolerance, such as high gastric residual volume, vomiting, and diarrhea. It covers common causes and provides a comparison of assessment methods and management strategies to improve patient outcomes.

Key Points

  • Gastrointestinal Symptoms: Key indicators of enteral nutrition intolerance include nausea, vomiting, abdominal distension, abdominal pain, diarrhea, and constipation.

  • High Gastric Residuals: While historically a primary measure, high gastric residual volumes (GRV) should be interpreted alongside other symptoms. Research suggests interventions are often unnecessary for GRVs under 500 mL.

  • Contributing Factors: Intolerance can result from underlying medical conditions (e.g., gastroparesis, sepsis), formula composition (e.g., high osmolality), feeding method, and medications (e.g., opioids).

  • Management Protocol: A stepwise approach to managing intolerance involves assessing the patient, modifying the feeding rate or formula, optimizing patient positioning, and, if necessary, using prokinetic agents or switching to post-pyloric feeding.

  • Preventive Measures: Measures like elevating the head of the bed to 30-45 degrees, careful medication review, and proper feeding technique are critical for preventing intolerance and associated risks like aspiration.

  • Interprofessional Care: Effective management often requires a collaborative approach involving physicians, nurses, dietitians, and pharmacists to tailor the feeding plan to the patient's needs and monitor for complications.

In This Article

Recognizing the Signs of Enteral Nutrition Intolerance

Intolerance to enteral nutrition (EN) is a common challenge in hospitalized patients, particularly those in the intensive care unit (ICU). It is a general term covering a spectrum of gastrointestinal (GI) symptoms that disrupt the successful delivery of nutrition through a feeding tube. Recognizing these signs early is essential for preventing adverse outcomes and ensuring the patient receives adequate nutritional support.

Gastrointestinal Symptoms

Patient-reported or observable GI symptoms are primary indicators of feeding intolerance. These can include a range of issues, from discomfort to more severe complications.

  • Nausea and Vomiting: The regurgitation of gastric contents is a clear sign that the body is not tolerating the feeding. This can range from a feeling of sickness to active emesis.
  • Abdominal Distension and Pain: The abdomen may appear visibly swollen or feel tight and firm to the touch. The patient may also complain of discomfort or pain.
  • Diarrhea: Defined as three or more loose or liquid stools per day, this symptom can be caused by the type of formula, feeding rate, or an underlying infection.
  • Constipation: While less direct, a lack of bowel movements can also signal impaired gastrointestinal motility and is associated with enteral feeding difficulties.
  • Increased Gastric Residual Volume (GRV): Historically, this was a primary indicator, measured by aspirating the stomach contents. A GRV of 200–500 mL or more was often considered a threshold for concern. However, recent research suggests that stopping feeds for GRVs less than 500 mL might not be necessary, especially without other signs of intolerance.

Potential Causes and Risk Factors

Multiple factors can contribute to a patient's inability to tolerate enteral feedings. Understanding the cause is crucial for effective management.

  • Underlying Medical Conditions: Conditions such as gastroparesis, intestinal pseudo-obstruction, and GI tract edema can impair motility and absorption. Critically ill patients with sepsis, pancreatitis, or abdominal surgery are also at higher risk.
  • Formula-Related Issues: The osmolality, fiber content, and fat concentration of the enteral formula can affect GI tolerance. Hyperosmolar formulas or those with high fat content may cause diarrhea or delayed gastric emptying.
  • Delivery Method and Rate: Bolus feedings may be less tolerated by some patients compared to continuous infusion, especially those with delayed gastric emptying. An overly rapid increase in the feeding rate can also overwhelm the GI system.
  • Medications: Certain medications, such as opioids, sedatives, and vasopressors, can decrease gastrointestinal motility and contribute to intolerance. Sorbitol, found in some liquid medications, can also cause diarrhea.
  • Tube Placement: Incorrect tube placement or migration can lead to complications. For example, a nasogastric tube that has migrated into the small bowel can cause reflux and aspiration.
  • Patient Positioning: Lying flat during or after feeding significantly increases the risk of aspiration and reflux. Keeping the head of the bed elevated 30-45° is a key preventive measure.

Management Strategies for Intolerance

When intolerance is suspected, a stepwise approach is necessary to address the underlying issues and restore successful enteral feeding.

  1. Assess and Monitor: Start by performing a comprehensive assessment, including evaluating GI function, checking tube placement, and reviewing medications. Continue to monitor for symptoms of intolerance.
  2. Modify Feeding Protocol: Consider slowing the infusion rate or transitioning from bolus to continuous feeding. The type of formula may also be adjusted, such as switching to a peptide-based or fiber-containing formula.
  3. Optimize Patient Position: Ensure the patient remains in a semi-recumbent position (30-45° angle) during and for at least 30-60 minutes after feeding.
  4. Administer Medications: Prokinetic agents like erythromycin or metoclopramide can be used to improve gastric motility if prescribed by a physician. Ensure all medications administered through the tube are compatible with the formula and crushed or prepared properly.
  5. Address Underlying Issues: Treat any infections, correct electrolyte imbalances, and consider adjusting medications that affect GI motility.
  6. Consider Post-Pyloric Feeding: If gastric feeding continues to fail, a post-pyloric feeding tube (e.g., nasojejunal or jejunostomy) can deliver nutrition directly into the small intestine, bypassing the stomach.

Comparison of Common Symptoms Indicating Enteral Intolerance

Symptom Primary Indication Potential Underlying Cause Management Action
Nausea/Vomiting Gastric overfilling, impaired motility Rapid infusion, high volume, certain medications (opioids) Slow feeding rate, switch to continuous feeding, use prokinetics
High Gastric Residual Volume Delayed gastric emptying Critically ill status, certain medications, underlying conditions Assess for other signs of intolerance; consider prokinetics or post-pyloric feeding
Abdominal Distension Gas accumulation, delayed motility Air administration during feeding, constipation, ileus Check for constipation, minimize air intake, consider motility agents
Diarrhea Malabsorption, infection, formula issues Formula type, rapid rate, medication side effects, contamination Reduce rate, switch formula, assess for infection, ensure aseptic technique

Conclusion

Intolerance of enteral nutrition is a complex issue with varied clinical manifestations and causes. The clearest indicators include a constellation of gastrointestinal symptoms such as nausea, vomiting, abdominal distension, diarrhea, and persistently high gastric residual volumes. However, as medical understanding evolves, a holistic assessment combining symptom review, careful monitoring, and evaluation of contributing factors is now considered best practice. Timely and appropriate intervention, which may include modifying feeding protocols, adjusting medication, or changing the feeding tube type, is crucial for improving patient outcomes and ensuring successful nutritional support. Healthcare providers must remain vigilant and apply an evidence-based approach to address these challenges effectively. For further detailed guidelines on managing enteral feeding complications, see resources from authoritative organizations such as the British Association for Parenteral and Enteral Nutrition (BAPEN).

Frequently Asked Questions

The most common signs include gastrointestinal symptoms such as nausea, vomiting, abdominal distension, abdominal pain, and diarrhea.

No, a high GRV alone is not a definitive indicator of intolerance. Many studies suggest that stopping or slowing feeding is not necessary for GRVs under 500 mL unless accompanied by other symptoms like nausea or vomiting.

Risk factors include critical illness, underlying conditions like gastroparesis, recent abdominal surgery, certain medications (e.g., opioids), formula composition, and poor patient positioning.

Diarrhea can be managed by slowing the feeding rate, changing to a formula with a different fiber content, ensuring proper hand hygiene to prevent contamination, and investigating potential medication side effects.

The head of the bed should be elevated to at least 30-45 degrees during feeding and for at least 30-60 minutes after to minimize the risk of aspiration.

Enteral nutrition uses the gastrointestinal tract for nutrient delivery (e.g., tube feeding), while parenteral nutrition delivers nutrients directly into the bloodstream intravenously, bypassing the digestive system entirely.

The provider should first assess the patient for symptoms, check tube placement, and review the feeding protocol. Initial management may involve slowing the rate or changing the formula, and further steps may include medications or alternative feeding routes if symptoms persist.

References

  1. 1
  2. 2
  3. 3
  4. 4

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice.